BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2006
View Archived Issues
Seroconversion seen with hepatitis B vaccine in phase IIa trial
Read More
Proapoptotic activity of a novel derivative of shikonin
Read More
Phase II study of NPI-32101 completes enrollment
Read More
Xoma and Aveo sign agreement to humanize AV-299
Read More
Senesco's Factor 5A inhibits tumor development in mice
Read More
AERx iDMS phase III program set to reopen
Read More
Angiogenic factors mediate the cardioprotective properties of sildenafil citrate
Read More
GLOBE study reveals resistance and efficacy with telbivudine in hepatitis B
Read More
Studies assess ranibizumab alone and with verteporfin PTD in macular degeneration
Read More
Emisphere to receive milestone payment for use of eligen in Novartis program
Read More
Inhibitex continues Veronate review
Read More
Amicus files to begin phase I studies of AT-2101 in Gaucher's disease
Read More
BioTie grants Britannia nalmefene marketing rights for U.K. and Ireland
Read More
Enrollment completed in phase III study of Corlux in psychotic major depression
Read More
Spanish companies establish consortium, Genius Pharma
Read More
Enrollment completed in phase IIb obesity study of AOD-9604
Read More
Oral direct thrombin inhibitor MPC-0920 begins phase I study
Read More
Phase III studies of tapentadol set for Q3
Read More
Phase I trial evaluates ENMD-1198 in patients with advanced cancer
Read More
Pharmaxis completes end of phase II meeting for Bronchitol
Read More
Encouraging findings from phase I study of PV-10 in recurrent breast cancer
Read More
Phase Ib/II trial studies CTCE-9908 in patients with late-stage cancers
Read More
NDA for controlled-release zileuton targeted for Q3
Read More
TNX-355 produces durable viral-load suppression in HIV patients
Read More
E.U. approval for NovoMix 30 label extension
Read More
Dacogen approved for myelodysplastic syndromes
Read More
Novel antiinfective agents revealed in recent patents
Read More
Anti-HIV agents reported in recent patent literature
Read More
Mount Sinai researchers identify important regulator of postmenopausal bone loss
Read More
RTK inhibition reduces retinal vascular permeability in animal models of diabetic macular edema
Read More
Silencing RTP801 gene with novel siRNA shows benefit in a murine model of CNV
Read More
Snapshots of recent studies on VEGF Trap presented at the ARVO meeting
Read More